Thomas D. Sequist, MD, MPH

During the coronavirus disease 2019 (COVID-19) pandemic, we found lower use of video vs telephone visits among older, Black, Hispanic, and Spanish-speaking patients, driven largely by clinician and practice factors.

The authors detail how population health management enables health systems to promote public health, strengthen health system resiliency, and support financial recovery during and beyond coronavirus disease 2019 (COVID-19).

Experience with risk-based contracting best predicts active engagement of accountable care organizations in reducing low-value medical services, mainly through physician education and encouraging shared decision making.

Decision support tools, disease registries, and patient engagement materials can improve population-based chronic kidney disease care.

Electronic health records data can accurately quantify overuse of clinical services and the risk factors that may trigger low-value testing and screening.

Patients who enrolled in a trial to lower low-density lipoprotein cholesterol spoke positively of the multifaceted intervention: pillbox monitoring and financial incentives were socially acceptable.

The authors surveyed physicians regarding “Choosing Wisely” and hypothesized drivers of overuse, finding high reported prevalence of hypothesized drivers of overuse and widespread support for cost-consciousness.